Singapore · Delayed Price · Currency is SGD Pacific Radiance Statistics
Total Valuation
SGX:RXS has a market cap or net worth of SGD 136.80 million. The enterprise value is 126.83 million.
| Market Cap | 136.80M |
| Enterprise Value | 126.83M |
Important Dates
The next estimated earnings date is Monday, May 11, 2026.
| Earnings Date | May 11, 2026 |
| Ex-Dividend Date | May 6, 2026 |
Share Statistics
SGX:RXS has 1.46 billion shares outstanding. The number of shares has increased by 5.60% in one year.
| Current Share Class | 1.46B |
| Shares Outstanding | 1.46B |
| Shares Change (YoY) | +5.60% |
| Shares Change (QoQ) | +6.01% |
| Owned by Insiders (%) | 69.69% |
| Owned by Institutions (%) | 2.84% |
| Float | 433.81M |
Valuation Ratios
The trailing PE ratio is 7.31 and the forward PE ratio is 7.38.
| PE Ratio | 7.31 |
| Forward PE | 7.38 |
| PS Ratio | 1.93 |
| PB Ratio | 1.09 |
| P/TBV Ratio | 1.09 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.68, with an EV/FCF ratio of -24.68.
| EV / Earnings | 6.25 |
| EV / Sales | 1.79 |
| EV / EBITDA | 7.68 |
| EV / EBIT | 13.33 |
| EV / FCF | -24.68 |
Financial Position
The company has a current ratio of 2.91, with a Debt / Equity ratio of 0.07.
| Current Ratio | 2.91 |
| Quick Ratio | 2.48 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | 0.59 |
| Debt / FCF | -1.79 |
| Interest Coverage | 23.54 |
Financial Efficiency
Return on equity (ROE) is 17.81% and return on invested capital (ROIC) is 7.43%.
| Return on Equity (ROE) | 17.81% |
| Return on Assets (ROA) | 3.45% |
| Return on Invested Capital (ROIC) | 7.43% |
| Return on Capital Employed (ROCE) | 6.14% |
| Weighted Average Cost of Capital (WACC) | 7.32% |
| Revenue Per Employee | 417,548 |
| Profits Per Employee | 119,370 |
| Employee Count | 170 |
| Asset Turnover | 0.46 |
| Inventory Turnover | 9.59 |
Taxes
| Income Tax | -2.30M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +129.27% in the last 52 weeks. The beta is 0.61, so SGX:RXS's price volatility has been lower than the market average.
| Beta (5Y) | 0.61 |
| 52-Week Price Change | +129.27% |
| 50-Day Moving Average | 0.09 |
| 200-Day Moving Average | 0.09 |
| Relative Strength Index (RSI) | 62.08 |
| Average Volume (20 Days) | 1,692,815 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SGX:RXS had revenue of SGD 70.98 million and earned 20.29 million in profits. Earnings per share was 0.01.
| Revenue | 70.98M |
| Gross Profit | 28.52M |
| Operating Income | 8.60M |
| Pretax Income | 18.02M |
| Net Income | 20.29M |
| EBITDA | 14.93M |
| EBIT | 8.60M |
| Earnings Per Share (EPS) | 0.01 |
Balance Sheet
The company has 19.02 million in cash and 9.22 million in debt, with a net cash position of 9.80 million or 0.01 per share.
| Cash & Cash Equivalents | 19.02M |
| Total Debt | 9.22M |
| Net Cash | 9.80M |
| Net Cash Per Share | 0.01 |
| Equity (Book Value) | 125.59M |
| Book Value Per Share | 0.09 |
| Working Capital | 43.31M |
Cash Flow
In the last 12 months, operating cash flow was -2.13 million and capital expenditures -3.01 million, giving a free cash flow of -5.14 million.
| Operating Cash Flow | -2.13M |
| Capital Expenditures | -3.01M |
| Depreciation & Amortization | 6.29M |
| Net Borrowing | -575,995 |
| Free Cash Flow | -5.14M |
| FCF Per Share | -0.00 |
Margins
Gross margin is 40.18%, with operating and profit margins of 12.11% and 28.59%.
| Gross Margin | 40.18% |
| Operating Margin | 12.11% |
| Pretax Margin | 25.39% |
| Profit Margin | 28.59% |
| EBITDA Margin | 21.04% |
| EBIT Margin | 12.11% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.00, which amounts to a dividend yield of 1.86%.
| Dividend Per Share | 0.00 |
| Dividend Yield | 1.86% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 3.47% |
| Buyback Yield | -5.60% |
| Shareholder Yield | -3.74% |
| Earnings Yield | 14.83% |
| FCF Yield | -3.76% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on September 12, 2022. It was a reverse split with a ratio of 0.1.
| Last Split Date | Sep 12, 2022 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
SGX:RXS has an Altman Z-Score of 1.25 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.25 |
| Piotroski F-Score | 4 |